Ilumetri 100 mg/1 ml, Injektionslösung in einer Fertigspritze

7680667840015 CH-66784 L04AC17 07.15.0.

Active substances:

Ilumetri 100 mg/1 ml, Injektionslösung in einer Fertigspritze
Ilumetri 100 mg/1 ml, Injektionslösung in einer Fertigspritze
Ilumetri 100 mg/1 ml, Injektionslösung in einer Fertigspritze
1 / 3
google

Details

Product number
6678401
CPT
-
Packaging group
2
Unit
Fertigspritze(n)
Composition
tildrakizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Ilumetri 100 mg/1 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/07/2026
Professional SmPC
Français
14/07/2026
Professional SmPC
Italien
14/07/2026

Detailed composition

Substance Quantity Type Category
tildrakizumabum
100.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Almirall AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
66784
Drug name
Ilumetri, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AC17
Authorization status
Z
Dispensation category
B
First authorization
18/04/2019
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Plaque Psoriasis bei Erwachsenen

Packaging details

Description (FR)
ILUMETRI 100 mg/1 ml sol inj 100 mg 2 pce
Description (DE)
ILUMETRI 100 mg/1 ml Inj Lös 100 mg 2 Stk
Market launch
18/04/2019
Market withdrawal
30/12/2025
Narcotic (BTM)
No

Other packaging sizes

ILUMETRI sol inj 100 mg/1ml seringue préremplie
1 FESP
View
ILUMETRI sol inj 200 mg/2ml seringue préremplie
1 FESP
View
Buy us a coffee Explore the data